INGEVITY+ Active Fixation Pace/Sense Lead Clinical Study

CompletedOBSERVATIONAL
Enrollment

109

Participants

Timeline

Start Date

August 6, 2020

Primary Completion Date

March 1, 2021

Study Completion Date

March 1, 2021

Conditions
Bradycardia
Interventions
DEVICE

INGEVITY+™ Pace/Sense Lead

The INGEVITY+ lead is indicated for chronic pacing and sensing in the right atrium and/or right ventricle when used with a compatible pulse generator.

Trial Locations (13)

23507

Sentara Norfolk General Hospital, Norfolk

30322

Emory University Hospital, Atlanta

35801

Heart Center Research, LLC, Huntsville

37205

Saint Thomas Health, Nashville

44710

Aultman Hospital, Canton

48048

Cardiovascular Institute of Michigan, Clinton Township

52242

University of Iowa Hospitals and Clinics, Iowa City

65807

Cox Health, Springfield

72401

Arrhythmia Research Group, Jonesboro

90505

Torrance Memorial Medical Center, Torrance

98664

PeaceHealth Southwest Medical, Bellingham

03102

Catholic Medical Center, Manchester

08015

Deborah Heart and Lung, Browns Mills

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY